![Michael Thurn](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Thurn
Direktor/Vorstandsmitglied bei
NEURIZON THERAPEUTICS LIMITED
Vermögen: 127 998 $ am 31.05.2026
Profil
Michael Thurn is the founder of Marp Therapeutics Pty Ltd. Current positions include Non-Executive Director at Arovella Therapeutics Ltd. starting in 2026, Director at Inmagene Biopharmaceuticals, Director at Impel Neuropharma, and Non-Executive Director at Neurizon Therapeutics Ltd. starting in 2026.
Former roles include Chief Executive Officer at Mimetica Pty Ltd. from 2006 to 2014, Chief Executive Officer at Neurizon Therapeutics Ltd. from 2023 to 2024, Chief Operating Officer & Executive Director at Botanix Pharmaceuticals Ltd. from 2019 to 2020, Managing Director at Spinifex Pharmaceuticals Pty Ltd., Director at Erasca, Inc., Team Leader at Kazia Therapeutics Ltd., Chief Operating Officer at YM BioSciences Australia Pty Ltd., Head-Drug Development at Xenome Ltd., and Senior Toxicologist at Therapeutic Goods Administration.
Education includes a doctorate from the University of Technology Sydney conferred in 1994.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 07.11.2024 | 2’869’276 ( 0.38% ) | 127 998 $ | 31.05.2026 |
Aktive Positionen von Michael Thurn
| Unternehmen | Position | Beginn |
|---|---|---|
| NEURIZON THERAPEUTICS LIMITED | Direktor/Vorstandsmitglied | 31.05.2024 |
| AROVELLA THERAPEUTICS LIMITED | Direktor/Vorstandsmitglied | 28.04.2026 |
Ehemalige bekannte Positionen von Michael Thurn
| Unternehmen | Position | Ende |
|---|---|---|
| NEURIZON THERAPEUTICS LIMITED | Vorstandsvorsitzender | 23.04.2024 |
| BOTANIX PHARMACEUTICALS LIMITED | Geschäftsführer | 26.02.2020 |
| ERASCA, INC. | Direktor/Vorstandsmitglied | - |
Marp Therapeutics Pty Ltd.
 Marp Therapeutics Pty Ltd. Medical/Nursing ServicesHealth Services Provides therapy services | Gründer | - |
Therapeutic Goods Administration | Corporate Officer/Principal | - |
Ausbildung von Michael Thurn
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
36
Beziehungen ersten Grades
12
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 12 |
|---|---|
Kazia Therapeutics Ltd.
 Kazia Therapeutics Ltd. BiotechnologyHealth Technology Engages in the business of pharmaceutical research and development | Health Technology |
Botanix Pharmaceuticals Ltd.
 Botanix Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Engages in the research and development of dermatology and antimicrobial products | Health Technology |
Arovella Therapeutics Ltd.
 Arovella Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals and distributes medical devices and consumables | Health Technology |
YM BioSciences Australia Pty Ltd.
 YM BioSciences Australia Pty Ltd. Pharmaceuticals: MajorHealth Technology Develops cancer treatment pharmaceuticals | Health Technology |
Xenome Ltd.
 Xenome Ltd. Pharmaceuticals: MajorHealth Technology Discovers and develops peptide pharmaceuticals | Health Technology |
Neurizon Therapeutics Ltd.
 Neurizon Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Discovers, develops and manufactures pharmaceutical products | Health Technology |
University of Technology Sydney
 University of Technology Sydney Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mimetica Pty Ltd.
 Mimetica Pty Ltd. Pharmaceuticals: MajorHealth Technology Develops products for the treatment of acne | Health Technology |
Spinifex Pharmaceuticals Pty Ltd.
 Spinifex Pharmaceuticals Pty Ltd. Pharmaceuticals: MajorHealth Technology Discovers and develops new drug candidates for the treatment & management of pain | Health Technology |
Therapeutic Goods Administration | |
Erasca, Inc.
 Erasca, Inc. Pharmaceuticals: MajorHealth Technology Develops, discovers and commercializes therapies for RAS/MAPK pathway-driven cancers | Health Technology |
Marp Therapeutics Pty Ltd.
Marp Therapeutics Pty Ltd. Medical/Nursing ServicesHealth Services Provides therapy services | Health Services |
